{"ticker": {"uuid": "dda313cb-6adf-45e8-82a2-9d0208c85e84", "symbol": "RGEN", "name": "Repligen Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Repligen (RGEN) Stock May Trade At Fair Value But At A Sales Premium", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPbnY1UVdUQWNwYU9SUjlmMHZkYXk3MXV6d0ZRQmVUNkY0N1FZNnVVaEMzNUFDT3NxT3RjQ3hIR1MtdmdIbTF6ZVVhSnVlYjZJdTFNY3ExYmNYN0hIb3NrQXNmMzFXYXR2N3k4WnYxUHN2ZHlva2NpcS1KeGMtV2lqamNodW1PWUFlaWFydXd5QXRoLUJVMHhJOS00eG1DUzVrX1R5ZGFXZlNUeXJtMVVkVXgzMjJMVkJubF92Wi10TEpKSmFwV0RKelNQbnpRa01ranZhRTh0VFRUZ9IB3wFBVV95cUxOVEgzcmlxcHNpRzIxakhFcnpPSW55NTM1RE5lUUR2TFdBSVcxcWtjQnpUSWY0aUJ3RHNhSlNWc09lOUJCOXZDYXhKXzBRek1YWTd1UGdMN1dPSmlQM1RuaXB6UncycllBSTBoQ3RhdlJHZEZZWlRmSnZmNE1mUHJvc2RuNmYtejEtQ2pSN0hIdW1KQ1N5aEtGU2EzbExKT0VQNVZ0NVdCT3ZkMnpPVEdKbFpuSENHVGR5dUlZcXZFT2djcWFheURva0Ryb1JhcHZtV2ZGOUl2THF6aXB4aGpV?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T01:03:48+00:00", "published_display": "16 Jul 2026 01:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen to report Q2 2026 financial results on July 28", "summary": "Repligen Corporation is set to announce its second-quarter 2026 financial results on July 28, 2026, covering the period ended June 30, 2026. The company will issue a press release before market open, followed by a conference call at 8:00 a.m. ET to discuss the results and provide", "url": "https://scanx.trade/stock-market-news/companies/repligen-to-report-q2-2026-financial-results-on-july-28/45668215", "source_name": "scanx.trade", "published_at": "2026-07-15T14:11:04", "published_display": "15 Jul 2026 14:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Schedules 8 a.m. ET Webcast for July 28 Results", "summary": "Repligen (NASDAQ: RGEN) announced it will report its Q2 2026 financial results on Tuesday, July 28, 2026. A press release will be issued before market open, followed by a conference call and webcast at 8:00 a.m. ET to discuss business updates and results for the quarter ended Jun", "url": "https://www.stocktitan.net/news/RGEN/repligen-to-report-second-quarter-2026-financial-r6x8pwnpp93g.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:11:03", "published_display": "15 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen to Report Second Quarter 2026 Financial Results", "summary": "Repligen Corporation (NASDAQ:RGEN) announced it will report its second quarter 2026 financial results on Tuesday, July 28, 2026. The company will issue a press release before market open and host a conference call at 8:00 a.m. ET to discuss business updates and financial results ", "url": "https://www.globenewswire.com/news-release/2026/07/15/3327601/24603/en/repligen-to-report-second-quarter-2026-financial-results.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T11:11:03", "published_display": "15 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Repligen Corporation Stocks", "summary": "This article lists numerous Exchange Traded Funds (ETFs) that hold Repligen Corporation stocks, categorizing them by issuer, management style, focus, expense ratio, and assets under management (AUM). It provides key financial metrics for each ETF, including market value of Replig", "url": "https://www.tradingview.com/symbols/LSX-870980/etfs/", "source_name": "TradingView", "published_at": "2026-07-13T19:42:50", "published_display": "13 Jul 2026 19:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Stock And 2 Dollar Beneficiaries Gaining Attention After Fed Rate Shift", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T13:02:18+00:00", "published_display": "13 Jul 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Repligen (RGEN) Stay Undervalued On Russell Index Removals And Margin Concerns?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T03:59:07+00:00", "published_display": "10 Jul 2026 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late to Buy Repligen Corp (RGEN) After 4.7% Rally? GF Value Says Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPY3E3ZmJPd3ZGWGdVYWJkRkxlcXNra1pxMjhzN3I0NWRpcWVFM3pxYUdqOFNEMkpyZElkMWV4RGZqNkJ5T2xVVkoyTnEzWFBUZ0xuaDdRSTlsNlJWb3g0QmVBd3RzdHlVcEEydHZfUHBHZVRLaXdiejBEc2JtZWV0dDY3eTh3bVNkTmJUT25QQmlqU1p0d1VVUHpSMTZENFFfQ3JLcDRkRkFteFlXdmxpLXIxc2pWZWVtTnlNLQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-09T22:54:30+00:00", "published_display": "09 Jul 2026 22:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen stock trades steadily as bioprocessing demand shapes investor focus", "summary": "Repligen stock (RGEN) is influenced by its role in the high-growth bioprocessing sector, where demand for biologics and advanced therapies drives recurring revenue. Investors focus on long-term factors like margins, capacity expansion, and broad biologics demand, rather than shor", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-stock-trades-steadily-as-bioprocessing-demand-shapes-investor/69734232", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:35:13", "published_display": "09 Jul 2026 17:35", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(RGEN) and the Role of Price-Sensitive Allocations", "summary": "This article provides an in-depth stock analysis for Repligen Corporation (NASDAQ: RGEN), highlighting neutral near-term readings and strong mid-term sentiment that may be stalling. It details AI-generated trading strategies including position trading, momentum breakout, and risk", "url": "https://news.stocktradersdaily.com/news_release/90/RGEN_and_the_Role_of_Price-Sensitive_Allocations_070926043602_1783629362.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T16:10:48", "published_display": "09 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors?", "summary": "Repligen (RGEN) was removed from multiple Russell growth benchmarks, including the Russell 1000 Growth and 3000 Growth Indexes, which may affect its liquidity and shareholder base. While this shift doesn't alter immediate operational drivers like order trends or margins, it highl", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgen/repligen/news/should-repligens-rgen-russell-growth-index-removal-require-a", "source_name": "Simply Wall Street", "published_at": "2026-07-08T05:10:38", "published_display": "08 Jul 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp business overview and stock context", "summary": "Repligen Corp specializes in bioprocessing technologies for biologic drug production, supplying equipment and solutions to pharmaceutical and biotech companies. Its business model focuses on filtration, separation, and fluid management systems, benefiting from the growing demand ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-corp-business-overview-and-stock-context/69717695", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T22:46:00", "published_display": "07 Jul 2026 22:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPLIGEN CORP : BENCHMARK RAISES TO BUY FROM HOLD", "summary": "Benchmark has upgraded its rating for Repligen Corporation from Hold to Buy. This indicates an increased positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/flash/22754444/repligen-corp-benchmark-raises-to-buy-from-hold", "source_name": "Moomoo", "published_at": "2026-07-07T20:11:00", "published_display": "07 Jul 2026 20:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/benchmark-upgrades-repligen-buy-hold-114356614.html", "source_name": "MT Newswires", "published_at": "2026-07-07T11:43:56+00:00", "published_display": "07 Jul 2026 11:43", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160", "summary": "Evercore has reiterated its Buy rating on Repligen (RGEN.US) and increased its target price to $160. This reflects the firm's continued confidence in the company's financial prospects and market position.", "url": "https://www.moomoo.com/news/post/72526594/evercore-maintains-repligen-rgenus-with-buy-rating-raises-target-price", "source_name": "Moomoo", "published_at": "2026-07-07T06:10:28", "published_display": "07 Jul 2026 06:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Repligen (RGEN)", "summary": "This article analyzes the historical performance of investing $1,000 in Repligen (RGEN) over 1, 5, and 10 years, detailing the total return and Compound Annual Growth Rate (CAGR). It also provides an annual performance comparison of RGEN against the S&P 500 and offers a company o", "url": "https://www.stocktitan.net/tools/stock-return-calculator/RGEN", "source_name": "Stock Titan", "published_at": "2026-07-04T08:41:07", "published_display": "04 Jul 2026 08:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen Corporation (RGEN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPSmV1c1Y4ZF9tZ1BTczlfaF96cmRrWEJmYUVOV3RJVmNRamVScEl3V3c1OWJsYnpZNW1JVXFDTGg1cHYxcDBqQktObU1xS2ZvSllYRXJzdlZYclRsNHo0Y1Zmank2djZXcElvMy1oNHFzX3A0VFJnaFhDWUg2dUNYMUxBelJVSW1tWE9NSndXalRqWEpKZk5ZTXhYMXREdlA5SmFN?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s Why Repligen Corp. (RGEN) Fell 28% in Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNUW5HOEZMdm5aVlY3bU9pd25vUUhDckduaC1lWG05RFVtVTBQem4wek04Ui1TdjI0SU5Zbk0zS0VnMEZnVGs1QWtiOVBWNzNBWjdIOWstT1BiVnVYNWl6Q0U3bm0yd3ZxSWV2YWxRTzFTSzdnMzhjQnVjNTBmQnc0a0ZJZWx5Nkt1RkQ1OVpWaWpyZG1PcG53?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation(NasdaqGS: RGEN) dropped from Russell Midcap Growth Benchmark", "summary": "Repligen Corporation (NasdaqGS: RGEN) has been removed from the Russell Midcap Growth Benchmark. This news follows a series of recent events for the company, including presentations at healthcare conferences and its Q1 2026 earnings report, where it posted better-than-expected ad", "url": "https://www.marketscreener.com/news/repligen-corporation-nasdaqgs-rgen-dropped-from-russell-midcap-growth-benchmark-ce7f5fdfdb8cf522", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:56:00", "published_display": "29 Jun 2026 16:56", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "The article provides a financial metric for Repligen Corporation (NASDAQ: RGEN), specifically its forward price-to-sales ratio. It indicates that the market was closed at the time of publication and there were no trades. The content offers a snapshot of a financial data point for", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:10:35", "published_display": "28 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "This page provides financial information for Repligen Corporation (NASDAQ:RGEN), specifically focusing on its forward Price to Earnings (P/E) ratio. It indicates that the market for RGEN is currently closed with no trades. The content is primarily a data placeholder from TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T21:41:22", "published_display": "27 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Repligen Corporation \u2013 BX:RGN", "summary": "The article displays the \"Price to book forward\" for Repligen Corporation (RGN) on the BX Swiss exchange. It notes that the market is currently closed with no trades. The content primarily shows financial data available through TradingView, including a historical overview, and hi", "url": "https://www.tradingview.com/symbols/BX-RGN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T13:41:22", "published_display": "27 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "This article displays the enterprise value to EBITDA forward for Repligen Corporation, traded as RGEN on the Nasdaq Stock Market. It presents the period, value, and change information for this financial metric. The content is primarily a data point from TradingView's financial an", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:10:12", "published_display": "27 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Repligen Corporation \u2013 BX:RGN", "summary": "The article focuses on the \"Enterprise value to revenue forward\" metric for Repligen Corporation, traded on the BX Swiss exchange under the symbol RGN. It presents this financial data point for the company. The content primarily highlights where to find this financial detail with", "url": "https://www.tradingview.com/symbols/BX-RGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:10:12", "published_display": "27 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Actuals & Estimates (DUS:RGN)", "summary": "This article provides financial actuals and estimates for Repligen Corporation (DUS:RGN), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It covers frequently asked questions regarding its stock ticker, forecast, historical prices, ", "url": "https://www.tradingview.com/symbols/DUS-RGN/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-27T03:41:22", "published_display": "27 Jun 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Jason Garland Sells Shares of Repligen Corp (RGEN)", "summary": "Jason Garland, CFO of a Repligen Corp (RGEN) subsidiary, sold 733 shares of the company on June 25, 2026. This transaction leaves him with 19,359 shares. The stock, trading at $145 with a market cap of $8.292 billion, is considered modestly undervalued with a price-to-GF-Value ra", "url": "https://www.gurufocus.com/news/8935007/insider-sell-jason-garland-sells-shares-of-repligen-corp-rgen", "source_name": "GuruFocus", "published_at": "2026-06-27T02:09:49", "published_display": "27 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Actuals & Estimates (NASDAQ:RGEN)", "summary": "This article provides an overview of Repligen Corporation (NASDAQ: RGEN) stock, including its current price, market capitalization, and historical performance. It details financial actuals and estimates, analyst forecasts for future price targets, and information on earnings repo", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:09:49", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) CFO completes 733-share Rule 10b5-1 stock sale", "summary": "Repligen's CFO, Jason K. Garland, sold 733 shares of the company's common stock at $145 per share in a pre-planned transaction. This sale, totaling $106,285, was executed under a Rule 10b5-1 trading plan adopted on December 8, 2025. Following the transaction, Garland directly own", "url": "https://www.stocktitan.net/sec-filings/RGEN/form-4-repligen-corp-insider-trading-activity-9985b23b2fca.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:09:49", "published_display": "26 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh Actuals & Estimates (BMFBOVESPA:R2GE34) \u2014 TradingView", "summary": "The article provides an overview of Repligen Corporation (BMFBOVESPA:R2GE34) on TradingView, focusing on its financial actuals and estimates. It highlights features for exploring reported financial data, analyst estimates across various statements, and comparing actual results wi", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-R2GE34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:55", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RGN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and financial overview for Repligen Corporation (RGN) stock. It includes analysts' price targets, past performance data, earnings reports, revenue figures, and other key financial metrics. The article also addresses frequently asked quest", "url": "https://www.tradingview.com/symbols/BX-RGN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:55", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 REPLIGEN CORP For: 25 June By Investing.com", "summary": "This article announces the filing of Form 144 for Repligen Corp (RGEN) on June 25. Form 144 indicates an intent to sell restricted securities. The brief notice provides the company name, the form type, and the date of the filing.", "url": "https://ng.investing.com/news/stock-market-news/form-144-repligen-corp-for-25-june-93CH-2574678", "source_name": "Investing.com Nigeria", "published_at": "2026-06-25T18:40:47", "published_display": "25 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] REPLIGEN CORP SEC Filing", "summary": "This article reports on a Form 144 SEC filing by Repligen Corp (RGEN). The filing indicates a proposed sale of 733 shares of common stock with an aggregate market value of $106,285, acquired through restricted stock vesting on November 18, 2024. The filing was accepted by SEC EDG", "url": "https://www.stocktitan.net/sec-filings/RGEN/144-repligen-corp-sec-filing-9ffa1bf27fbc.html", "source_name": "Stock Titan", "published_at": "2026-06-25T17:40:47", "published_display": "25 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen jumps as investors revisit strong Q1 results and bioprocessing recovery outlook | RGEN Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNTmQ1U3lwTkdOeERhMGZSNzRpQ0JnU2NLVnNNaFNGdy1oMEQ5b011c3YwY01xU0xxVzhjUWVmNHpOazVPSEVhcVBrSE1ja3VIemNFT1B2dVdDdmpTbUhaTjRPV3hxRnRFUndicjVWQVRSU1FULS1JZzVUUmRWM0RKNTBfMVl4blBHc1B1YUlSNmQ3RUVMTFRNQWgzYVVWU3FHUzZGWVl5MDBVV2NIOUVuaml3R1NXSmtBRmZDdkJ3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Dropped Following the Earnings Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMjN6ZWx4eWhZMUExSmM0dGxyUkhNX2V2STJqMXFKbFZ5eFJfemhLdTY0WkFoZ2E3dlAybmJBNlB6NUVOdGRCMHMzT0U4MW5aU2pwTnEzZC15TjFDdzhSNFV0WTFXRmQtVmV0ZlAwZGdFWEZYSGJkZnVtRFJ2aVpRSW55aktCTHBJYmRHX0l6T0k4NTlHWEVvMUJwbl96Q3R6N0NpeHRVbGs?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors", "summary": "Repligen Corp (RGEN) shares fell 4.1% on June 22, 2026, dropping to $126.67. Despite this, the stock is considered 28.0% undervalued according to its GF Value\u2122 of $175.89, and holds a strong GF Score\u2122 of 83/100, primarily due to high growth potential. However, recent insider sell", "url": "https://www.gurufocus.com/news/8926045/repligen-corp-rgen-shares-fall-41-what-gf-score-of-83-tells-investors", "source_name": "GuruFocus", "published_at": "2026-06-23T00:39:15", "published_display": "23 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Stock Analysis: Assessing a 33% Upside Potential in Bioprocessing Innovation", "summary": "Repligen Corporation (RGEN) is a significant player in the bioprocessing sector within the healthcare industry, with a market capitalization of $7.45 billion. Analysts are optimistic, projecting a 33.39% upside potential from its current trading price of $132.02, supported by str", "url": "https://www.directorstalkinterviews.com/repligen-corporation-rgen-stock-analysis-assessing-a-33-upside-potential-in-bioprocessing-innovation/4121254393", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-22T14:12:25", "published_display": "22 Jun 2026 14:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Stock - Long-term strategy and bioprocessing niche", "summary": "This article focuses on Repligen (US7607591002), a specialized life-science tools provider, and its long-term strategy in the bioprocessing market. It highlights the company's business model, which centers on supplying technologies for biologic drug manufacturing, positioning it ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-stock-long-term-strategy-and-bioprocessing-niche/69592596", "source_name": "AD HOC NEWS", "published_at": "2026-06-20T18:39:41", "published_display": "20 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools", "summary": "Osterweis Capital Management's Q1 2026 investor update highlighted Repligen Corporation (NASDAQ: RGEN), noting its underperformance due to a general softening in enthusiasm for life sciences tools. Despite this, the fund remains positive about Repligen, citing its lack of exposur", "url": "https://www.insidermonkey.com/blog/repligen-corporation-rgen-slid-on-softened-enthusiasm-for-life-sciences-tools-1784930/", "source_name": "Insider Monkey", "published_at": "2026-06-19T08:48:00", "published_display": "19 Jun 2026 08:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Stock Analysis: Exploring a 55% Potential Upside for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxObXFyZER3OGhDT2xMWGpvVmRpTzZLZWJVc1ZiR3dVdW40aWFYNXRpUzVsajlwVEIwRlloUGJzaFZPMHR1YlktS1JJTW9KM1MzRllaSXFPeEpXSFpuRzhWaXlKOWJUa1hkZ0tUT0p0SjFsNmdURXRnMklkTG91dXFOSDllNklnanRER291S0dOSnNxUlMzT0lWcy16RXF5bHpjRmRFWExCSXA5ZkowUm9vSS15Q3R6dDBROThBWXNjX2RrREYxY3Rja2tOQ3lxbWQtR1ZR?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Repligen (RGEN) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNUDc0NVdjZkxpVzZuQ2kzeF9HVHZuNGVIc2ZHNlFRS1hFUmgzYnBwOVdEMU5QT2liS0s1TTByZVdPTno5UVN6XzRZZGQ5WW1SMFIyYjFWcVhXNG85R2VmcjlyRWlMVHR3OEpqcGpvazFmS0cwU0FIQVJkOGdaaktsd0g5RFFxaTFCd094S2hlaDkxNWVNTUpSS1JFVDBZbzJ2RmdVcy1KRQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays Maintains an \u201cOverweight Rating\u201d on Repligen Corporation (RGEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNV1RtY3RDSmVyam9fVFBJUWJ1X2tmdnlWM3FIVlRLelFFSDk5aFRVekhUOEstOFFmUDRsc3NOaUNtVy1LOG9KQm40WW5XRF84eVFhemlocUU1V0ViOEw2TGhsRno5RDh3WUN0YTFiSG9kaXJaWGp4SGZEd3pGcXdiN0RGcUlZNXFlMlYzdmluS01RemRxRHBiUHE5ZEFmMFVMRno3dTMyb1VYSjN6Q0hZbVVGRmY?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNWng1d2pVMmdGdF9meWtXbjFxNjJvOVpRWEhrbFBzTEExbTZRb0JkV2YyNnI3S0VNRUdpLVFYQWRxTUVNSGlISVU4b2Rram5TNWZfREpMSnBMSWw3c3J4NzA5N0VqMjNqUXl4elE5VFNyRjctQldoNWo3YzBYclJJRlVnQ3QxQU5ibUgxeWZiUkJUMXZudFRWRUNpNHdCS004Q1E?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPSEUtV0RvUW9DTXZwOGtNbU9hT3o3bUY1R3J2U3ZwMXFFN29hUW50MHhtWUQyODRWdnNXM2lqLTNoeEROcndUaG8zODUwOGc5cjZsWkJYU2tORDNTNENQMFl4bzhqeG1XNUNRdy1tWFl5aU5fRlhZODBRRk1fTk15dTd2SnY2YUU4cE1wYm9zTzRLZmR2d041Y1l1RFlMS1lwd05nSUZ3aTdkQmJrTEZkQVpZX0hGMVVVM2hNQjQ1Z08yMm1iZGdQMzFvMG1wT1JLYURMX1pBU1NVcnk0UVl1RWln?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Shares Skyrocket, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPYUpmdElNRnJJSkVzOGptRzFobExlUGdodWk4eXRhXzBxaXpiQ1dTNzI3cEtwaTBlbzhLbm1NVzQ2cVBlRl9FcUg3YVUwcGVBMDdZMGlvMGZ2QTFUX2ViSnNsOU4tTXBwOWRnLURhQUpLLVdZdVRyeGtlTW11YzNaMG1qN1h5TzNGdzBDTkx4cXJ3QzFGNWY4NHM2VkZaaU1BTDM3WlVvTnlNYkRYekxxSGIwSUo?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen (RGEN) Starting To Look Attractive After Its Sharp Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQRlFrRzlnSmNELURHaFlhS0I0aDVWX3UzT042a3RuNmp5cHdKWk1nMlE2ZXBXaHhsT0U0RVU3ODZ4RXB2aHFpM0FyV0tJUTF5anlCRmhYSXh0UzZMbHB2eWtuVEdyVWRuTkdnanN0ekZQeTlnTFR6ckhGcEpvTXFYaHZFVlM0ckV1cm9lSmt1WFIwSVo3V21QQ3VIQ1VPR1hheU1Lb2FB?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen (RGEN) Offering Value After A 28.5% Year To Date Share Price Decline", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNVXJkQUxyYW05UVNfejA3RU81SG50aGRBbTdsUWtIRUVWV2dPX1h4QVN5MEtsaDNXbmtUOG9fR3p0RnVqUE5XdUw3WllFRUpIY0otUkc3emM2TmNIVmFpQy1ORDdPdV9JNGhRVWZqQ0tvUUZLZ1kxUWJJVlowcGxqTkN4OTcwTDYzTFZheWcyTkZPMnliOEF1WG55ZERqYnNXdWRvaWRB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Repligen (RGEN) Shares Are Plunging Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQSmVyeFFVaWw5WDlsd3RKSm5oZXhLRDRvd3Y3SFNmUE5UUmw3WnFBQkRXa2pZR2lKY2NwakJRQ0lCaXdELXhKNzduVWRGZ0pMZk1JOUJSMThoYWFBTC1tNU9xeWF1djJ2TXJVUzhTaFMtRnN5cVdfTUNHaHh2R0V0bTRCekhpb1NTR0JTT2hzSTBzZkR4anpiQWF2ME9xM1U?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen slides 8.3% as CEO share sale disclosure weighs on sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNTGpReHNueXBMRXVGbi1lM1Rma0RUb09tejR5LTVEZ2JPckFRd29HZlAybmVJZWF1OHkwX1BuWDBmMUtsdUZhcXFUdXljX3gtdUdFaXl4LUREZDRzX3c5Wk1rUy0tVlNHb29WdFVKUkJ1bnp1Y3dJMVBhSG92RkZ4ZHp4UEY5ODBiaE1yYktDMThmS3BsMnpXeTNsLUtkNTZKbTI5bzVfSQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen plans a May 5 premarket earnings release and 8 a.m. webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPendyekJ2LV93bzhxWGk5S0hfbVRsZ1FaWWxocFRyMHk3WXoybTRxazVpdzlyc3FvZjM2WWdfZHlfXzJiR0pnRHptWnhyaUxUZzJvQ0Y4Ylc3YXFlZlZtX2FFVk1rM0RGcWNTd2M3V1ZXOHRVYnhiN1ZkWktkTTUyalNxY0hPbk1IWHlObWF0Q0Y2ekJMbjIyamgxZFBoLS01aVJaYQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Valuation Check After Mixed Share Price Returns And High P/E Multiple", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbHpKSjdFWjhDRFJnd0lzY001XzVUdS1hNEpmcW1hZzhFdV8ydE5BSU9NQ1pDU2ZrVDVEUG1CMEoxN3pWdk92eF9IZ3UtYmNaNkFoUmZNMDZ0cG5qVHpEM1pDVmc3MDBhY29uMlUtNnJRekVXX0xSQ2ZZcHhQMzJuS3BvN1hfYW5lZ2RTVTBucFVIcE4ycGNQc0lLOWtGQzNFUUE?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNb1BzWEZYRkhydkxxUEF2ZUJOQVIyLTU1VlFubFM0TkgzZFNPM2QwWmYzaWhsQnFnZU5qQS05S1ZDLThwT3JKTnlxTGhMblZQTlFBb1NGS0h6TlMwdTBXMzVoWHZMV1JDVGFLSTQ1UEg4MG5RclE5X3BNMVdQQ1JoZG5RbTFfQnVIalVWa2s4SHBFdw?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (NASDAQ: RGEN) Eddleman trusts report passive stake under 5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOTVFyUWpURGhRYWcwdHkyOVpTUDViTmlyR1otREdJUDN6Qk5kSEZMdGVNZGdxZDEzWTZQQUJTSEd5eVNmSzB2cnU0MTdlMzdIanA0a3Mzb0FMSl9wejJxejlrcXlhVFFiSHBJQ0NxOVlKNG5UMlRBd2RuS3Y5VWRWaDZXYWV3dkNUcm1WVl9wUTB4Q2FUbEFYMjZSZ3pVMTlzS2lOd1FSVHlkMU5UU19EaE1oMWhMX1o2QlZJU1pwX29hVHdEUzJR?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Repligen (RGEN) Stock May Trade At Fair Value But At A Sales Premium", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T01:03:48+00:00", "published_display": "16 Jul 2026 01:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen to report Q2 2026 financial results on July 28", "summary": "Repligen Corporation is set to announce its second-quarter 2026 financial results on July 28, 2026, covering the period ended June 30, 2026. The company will issue a press release before market open, followed by a conference call at 8:00 a.m. ET to discuss the results and provide", "url": "https://scanx.trade/stock-market-news/companies/repligen-to-report-q2-2026-financial-results-on-july-28/45668215", "source_name": "scanx.trade", "published_at": "2026-07-15T14:11:04", "published_display": "15 Jul 2026 14:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Schedules 8 a.m. ET Webcast for July 28 Results", "summary": "Repligen (NASDAQ: RGEN) announced it will report its Q2 2026 financial results on Tuesday, July 28, 2026. A press release will be issued before market open, followed by a conference call and webcast at 8:00 a.m. ET to discuss business updates and results for the quarter ended Jun", "url": "https://www.stocktitan.net/news/RGEN/repligen-to-report-second-quarter-2026-financial-r6x8pwnpp93g.html", "source_name": "Stock Titan", "published_at": "2026-07-15T12:11:03", "published_display": "15 Jul 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen to Report Second Quarter 2026 Financial Results", "summary": "Repligen Corporation (NASDAQ:RGEN) announced it will report its second quarter 2026 financial results on Tuesday, July 28, 2026. The company will issue a press release before market open and host a conference call at 8:00 a.m. ET to discuss business updates and financial results ", "url": "https://www.globenewswire.com/news-release/2026/07/15/3327601/24603/en/repligen-to-report-second-quarter-2026-financial-results.html", "source_name": "GlobeNewswire", "published_at": "2026-07-15T11:11:03", "published_display": "15 Jul 2026 11:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Repligen Corporation Stocks", "summary": "This article lists numerous Exchange Traded Funds (ETFs) that hold Repligen Corporation stocks, categorizing them by issuer, management style, focus, expense ratio, and assets under management (AUM). It provides key financial metrics for each ETF, including market value of Replig", "url": "https://www.tradingview.com/symbols/LSX-870980/etfs/", "source_name": "TradingView", "published_at": "2026-07-13T19:42:50", "published_display": "13 Jul 2026 19:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Stock And 2 Dollar Beneficiaries Gaining Attention After Fed Rate Shift", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T13:02:18+00:00", "published_display": "13 Jul 2026 13:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Repligen (RGEN) Stay Undervalued On Russell Index Removals And Margin Concerns?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-10T03:59:07+00:00", "published_display": "10 Jul 2026 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late to Buy Repligen Corp (RGEN) After 4.7% Rally? GF Value Says Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPY3E3ZmJPd3ZGWGdVYWJkRkxlcXNra1pxMjhzN3I0NWRpcWVFM3pxYUdqOFNEMkpyZElkMWV4RGZqNkJ5T2xVVkoyTnEzWFBUZ0xuaDdRSTlsNlJWb3g0QmVBd3RzdHlVcEEydHZfUHBHZVRLaXdiejBEc2JtZWV0dDY3eTh3bVNkTmJUT25QQmlqU1p0d1VVUHpSMTZENFFfQ3JLcDRkRkFteFlXdmxpLXIxc2pWZWVtTnlNLQ?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-09T22:54:30+00:00", "published_display": "09 Jul 2026 22:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen stock trades steadily as bioprocessing demand shapes investor focus", "summary": "Repligen stock (RGEN) is influenced by its role in the high-growth bioprocessing sector, where demand for biologics and advanced therapies drives recurring revenue. Investors focus on long-term factors like margins, capacity expansion, and broad biologics demand, rather than shor", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-stock-trades-steadily-as-bioprocessing-demand-shapes-investor/69734232", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T17:35:13", "published_display": "09 Jul 2026 17:35", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(RGEN) and the Role of Price-Sensitive Allocations", "summary": "This article provides an in-depth stock analysis for Repligen Corporation (NASDAQ: RGEN), highlighting neutral near-term readings and strong mid-term sentiment that may be stalling. It details AI-generated trading strategies including position trading, momentum breakout, and risk", "url": "https://news.stocktradersdaily.com/news_release/90/RGEN_and_the_Role_of_Price-Sensitive_Allocations_070926043602_1783629362.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-09T16:10:48", "published_display": "09 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should Repligen's (RGEN) Russell Growth Index Removal Require Action From Current Investors?", "summary": "Repligen (RGEN) was removed from multiple Russell growth benchmarks, including the Russell 1000 Growth and 3000 Growth Indexes, which may affect its liquidity and shareholder base. While this shift doesn't alter immediate operational drivers like order trends or margins, it highl", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgen/repligen/news/should-repligens-rgen-russell-growth-index-removal-require-a", "source_name": "Simply Wall Street", "published_at": "2026-07-08T05:10:38", "published_display": "08 Jul 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp business overview and stock context", "summary": "Repligen Corp specializes in bioprocessing technologies for biologic drug production, supplying equipment and solutions to pharmaceutical and biotech companies. Its business model focuses on filtration, separation, and fluid management systems, benefiting from the growing demand ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-corp-business-overview-and-stock-context/69717695", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T22:46:00", "published_display": "07 Jul 2026 22:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REPLIGEN CORP : BENCHMARK RAISES TO BUY FROM HOLD", "summary": "Benchmark has upgraded its rating for Repligen Corporation from Hold to Buy. This indicates an increased positive outlook on the company's stock performance.", "url": "https://www.moomoo.com/news/flash/22754444/repligen-corp-benchmark-raises-to-buy-from-hold", "source_name": "Moomoo", "published_at": "2026-07-07T20:11:00", "published_display": "07 Jul 2026 20:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/benchmark-upgrades-repligen-buy-hold-114356614.html", "source_name": "MT Newswires", "published_at": "2026-07-07T11:43:56+00:00", "published_display": "07 Jul 2026 11:43", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160", "summary": "Evercore has reiterated its Buy rating on Repligen (RGEN.US) and increased its target price to $160. This reflects the firm's continued confidence in the company's financial prospects and market position.", "url": "https://www.moomoo.com/news/post/72526594/evercore-maintains-repligen-rgenus-with-buy-rating-raises-target-price", "source_name": "Moomoo", "published_at": "2026-07-07T06:10:28", "published_display": "07 Jul 2026 06:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Repligen (RGEN)", "summary": "This article analyzes the historical performance of investing $1,000 in Repligen (RGEN) over 1, 5, and 10 years, detailing the total return and Compound Annual Growth Rate (CAGR). It also provides an annual performance comparison of RGEN against the S&P 500 and offers a company o", "url": "https://www.stocktitan.net/tools/stock-return-calculator/RGEN", "source_name": "Stock Titan", "published_at": "2026-07-04T08:41:07", "published_display": "04 Jul 2026 08:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen Corporation (RGEN) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPSmV1c1Y4ZF9tZ1BTczlfaF96cmRrWEJmYUVOV3RJVmNRamVScEl3V3c1OWJsYnpZNW1JVXFDTGg1cHYxcDBqQktObU1xS2ZvSllYRXJzdlZYclRsNHo0Y1Zmank2djZXcElvMy1oNHFzX3A0VFJnaFhDWUg2dUNYMUxBelJVSW1tWE9NSndXalRqWEpKZk5ZTXhYMXREdlA5SmFN?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s Why Repligen Corp. (RGEN) Fell 28% in Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNUW5HOEZMdm5aVlY3bU9pd25vUUhDckduaC1lWG05RFVtVTBQem4wek04Ui1TdjI0SU5Zbk0zS0VnMEZnVGs1QWtiOVBWNzNBWjdIOWstT1BiVnVYNWl6Q0U3bm0yd3ZxSWV2YWxRTzFTSzdnMzhjQnVjNTBmQnc0a0ZJZWx5Nkt1RkQ1OVpWaWpyZG1PcG53?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation(NasdaqGS: RGEN) dropped from Russell Midcap Growth Benchmark", "summary": "Repligen Corporation (NasdaqGS: RGEN) has been removed from the Russell Midcap Growth Benchmark. This news follows a series of recent events for the company, including presentations at healthcare conferences and its Q1 2026 earnings report, where it posted better-than-expected ad", "url": "https://www.marketscreener.com/news/repligen-corporation-nasdaqgs-rgen-dropped-from-russell-midcap-growth-benchmark-ce7f5fdfdb8cf522", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:56:00", "published_display": "29 Jun 2026 16:56", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "The article provides a financial metric for Repligen Corporation (NASDAQ: RGEN), specifically its forward price-to-sales ratio. It indicates that the market was closed at the time of publication and there were no trades. The content offers a snapshot of a financial data point for", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:10:35", "published_display": "28 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "This page provides financial information for Repligen Corporation (NASDAQ:RGEN), specifically focusing on its forward Price to Earnings (P/E) ratio. It indicates that the market for RGEN is currently closed with no trades. The content is primarily a data placeholder from TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T21:41:22", "published_display": "27 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Repligen Corporation \u2013 BX:RGN", "summary": "The article displays the \"Price to book forward\" for Repligen Corporation (RGN) on the BX Swiss exchange. It notes that the market is currently closed with no trades. The content primarily shows financial data available through TradingView, including a historical overview, and hi", "url": "https://www.tradingview.com/symbols/BX-RGN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T13:41:22", "published_display": "27 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Repligen Corporation \u2013 NASDAQ:RGEN", "summary": "This article displays the enterprise value to EBITDA forward for Repligen Corporation, traded as RGEN on the Nasdaq Stock Market. It presents the period, value, and change information for this financial metric. The content is primarily a data point from TradingView's financial an", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T12:10:12", "published_display": "27 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Repligen Corporation \u2013 BX:RGN", "summary": "The article focuses on the \"Enterprise value to revenue forward\" metric for Repligen Corporation, traded on the BX Swiss exchange under the symbol RGN. It presents this financial data point for the company. The content primarily highlights where to find this financial detail with", "url": "https://www.tradingview.com/symbols/BX-RGN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:10:12", "published_display": "27 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Actuals & Estimates (DUS:RGN)", "summary": "This article provides financial actuals and estimates for Repligen Corporation (DUS:RGN), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It covers frequently asked questions regarding its stock ticker, forecast, historical prices, ", "url": "https://www.tradingview.com/symbols/DUS-RGN/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-27T03:41:22", "published_display": "27 Jun 2026 03:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Jason Garland Sells Shares of Repligen Corp (RGEN)", "summary": "Jason Garland, CFO of a Repligen Corp (RGEN) subsidiary, sold 733 shares of the company on June 25, 2026. This transaction leaves him with 19,359 shares. The stock, trading at $145 with a market cap of $8.292 billion, is considered modestly undervalued with a price-to-GF-Value ra", "url": "https://www.gurufocus.com/news/8935007/insider-sell-jason-garland-sells-shares-of-repligen-corp-rgen", "source_name": "GuruFocus", "published_at": "2026-06-27T02:09:49", "published_display": "27 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Actuals & Estimates (NASDAQ:RGEN)", "summary": "This article provides an overview of Repligen Corporation (NASDAQ: RGEN) stock, including its current price, market capitalization, and historical performance. It details financial actuals and estimates, analyst forecasts for future price targets, and information on earnings repo", "url": "https://www.tradingview.com/symbols/NASDAQ-RGEN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:09:49", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) CFO completes 733-share Rule 10b5-1 stock sale", "summary": "Repligen's CFO, Jason K. Garland, sold 733 shares of the company's common stock at $145 per share in a pre-planned transaction. This sale, totaling $106,285, was executed under a Rule 10b5-1 trading plan adopted on December 8, 2025. Following the transaction, Garland directly own", "url": "https://www.stocktitan.net/sec-filings/RGEN/form-4-repligen-corp-insider-trading-activity-9985b23b2fca.html", "source_name": "Stock Titan", "published_at": "2026-06-26T20:09:49", "published_display": "26 Jun 2026 20:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh Actuals & Estimates (BMFBOVESPA:R2GE34) \u2014 TradingView", "summary": "The article provides an overview of Repligen Corporation (BMFBOVESPA:R2GE34) on TradingView, focusing on its financial actuals and estimates. It highlights features for exploring reported financial data, analyst estimates across various statements, and comparing actual results wi", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-R2GE34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:55", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RGN Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and financial overview for Repligen Corporation (RGN) stock. It includes analysts' price targets, past performance data, earnings reports, revenue figures, and other key financial metrics. The article also addresses frequently asked quest", "url": "https://www.tradingview.com/symbols/BX-RGN/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:55", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 REPLIGEN CORP For: 25 June By Investing.com", "summary": "This article announces the filing of Form 144 for Repligen Corp (RGEN) on June 25. Form 144 indicates an intent to sell restricted securities. The brief notice provides the company name, the form type, and the date of the filing.", "url": "https://ng.investing.com/news/stock-market-news/form-144-repligen-corp-for-25-june-93CH-2574678", "source_name": "Investing.com Nigeria", "published_at": "2026-06-25T18:40:47", "published_display": "25 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] REPLIGEN CORP SEC Filing", "summary": "This article reports on a Form 144 SEC filing by Repligen Corp (RGEN). The filing indicates a proposed sale of 733 shares of common stock with an aggregate market value of $106,285, acquired through restricted stock vesting on November 18, 2024. The filing was accepted by SEC EDG", "url": "https://www.stocktitan.net/sec-filings/RGEN/144-repligen-corp-sec-filing-9ffa1bf27fbc.html", "source_name": "Stock Titan", "published_at": "2026-06-25T17:40:47", "published_display": "25 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen jumps as investors revisit strong Q1 results and bioprocessing recovery outlook | RGEN Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNTmQ1U3lwTkdOeERhMGZSNzRpQ0JnU2NLVnNNaFNGdy1oMEQ5b011c3YwY01xU0xxVzhjUWVmNHpOazVPSEVhcVBrSE1ja3VIemNFT1B2dVdDdmpTbUhaTjRPV3hxRnRFUndicjVWQVRSU1FULS1JZzVUUmRWM0RKNTBfMVl4blBHc1B1YUlSNmQ3RUVMTFRNQWgzYVVWU3FHUzZGWVl5MDBVV2NIOUVuaml3R1NXSmtBRmZDdkJ3?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Dropped Following the Earnings Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMjN6ZWx4eWhZMUExSmM0dGxyUkhNX2V2STJqMXFKbFZ5eFJfemhLdTY0WkFoZ2E3dlAybmJBNlB6NUVOdGRCMHMzT0U4MW5aU2pwTnEzZC15TjFDdzhSNFV0WTFXRmQtVmV0ZlAwZGdFWEZYSGJkZnVtRFJ2aVpRSW55aktCTHBJYmRHX0l6T0k4NTlHWEVvMUJwbl96Q3R6N0NpeHRVbGs?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tells Investors", "summary": "Repligen Corp (RGEN) shares fell 4.1% on June 22, 2026, dropping to $126.67. Despite this, the stock is considered 28.0% undervalued according to its GF Value\u2122 of $175.89, and holds a strong GF Score\u2122 of 83/100, primarily due to high growth potential. However, recent insider sell", "url": "https://www.gurufocus.com/news/8926045/repligen-corp-rgen-shares-fall-41-what-gf-score-of-83-tells-investors", "source_name": "GuruFocus", "published_at": "2026-06-23T00:39:15", "published_display": "23 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Stock Analysis: Assessing a 33% Upside Potential in Bioprocessing Innovation", "summary": "Repligen Corporation (RGEN) is a significant player in the bioprocessing sector within the healthcare industry, with a market capitalization of $7.45 billion. Analysts are optimistic, projecting a 33.39% upside potential from its current trading price of $132.02, supported by str", "url": "https://www.directorstalkinterviews.com/repligen-corporation-rgen-stock-analysis-assessing-a-33-upside-potential-in-bioprocessing-innovation/4121254393", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-22T14:12:25", "published_display": "22 Jun 2026 14:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Stock - Long-term strategy and bioprocessing niche", "summary": "This article focuses on Repligen (US7607591002), a specialized life-science tools provider, and its long-term strategy in the bioprocessing market. It highlights the company's business model, which centers on supplying technologies for biologic drug manufacturing, positioning it ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/repligen-stock-long-term-strategy-and-bioprocessing-niche/69592596", "source_name": "AD HOC NEWS", "published_at": "2026-06-20T18:39:41", "published_display": "20 Jun 2026 18:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools", "summary": "Osterweis Capital Management's Q1 2026 investor update highlighted Repligen Corporation (NASDAQ: RGEN), noting its underperformance due to a general softening in enthusiasm for life sciences tools. Despite this, the fund remains positive about Repligen, citing its lack of exposur", "url": "https://www.insidermonkey.com/blog/repligen-corporation-rgen-slid-on-softened-enthusiasm-for-life-sciences-tools-1784930/", "source_name": "Insider Monkey", "published_at": "2026-06-19T08:48:00", "published_display": "19 Jun 2026 08:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corporation (RGEN) Stock Analysis: Exploring a 55% Potential Upside for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxObXFyZER3OGhDT2xMWGpvVmRpTzZLZWJVc1ZiR3dVdW40aWFYNXRpUzVsajlwVEIwRlloUGJzaFZPMHR1YlktS1JJTW9KM1MzRllaSXFPeEpXSFpuRzhWaXlKOWJUa1hkZ0tUT0p0SjFsNmdURXRnMklkTG91dXFOSDllNklnanRER291S0dOSnNxUlMzT0lWcy16RXF5bHpjRmRFWExCSXA5ZkowUm9vSS15Q3R6dDBROThBWXNjX2RrREYxY3Rja2tOQ3lxbWQtR1ZR?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Repligen (RGEN) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNUDc0NVdjZkxpVzZuQ2kzeF9HVHZuNGVIc2ZHNlFRS1hFUmgzYnBwOVdEMU5QT2liS0s1TTByZVdPTno5UVN6XzRZZGQ5WW1SMFIyYjFWcVhXNG85R2VmcjlyRWlMVHR3OEpqcGpvazFmS0cwU0FIQVJkOGdaaktsd0g5RFFxaTFCd094S2hlaDkxNWVNTUpSS1JFVDBZbzJ2RmdVcy1KRQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays Maintains an \u201cOverweight Rating\u201d on Repligen Corporation (RGEN)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNV1RtY3RDSmVyam9fVFBJUWJ1X2tmdnlWM3FIVlRLelFFSDk5aFRVekhUOEstOFFmUDRsc3NOaUNtVy1LOG9KQm40WW5XRF84eVFhemlocUU1V0ViOEw2TGhsRno5RDh3WUN0YTFiSG9kaXJaWGp4SGZEd3pGcXdiN0RGcUlZNXFlMlYzdmluS01RemRxRHBiUHE5ZEFmMFVMRno3dTMyb1VYSjN6Q0hZbVVGRmY?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNWng1d2pVMmdGdF9meWtXbjFxNjJvOVpRWEhrbFBzTEExbTZRb0JkV2YyNnI3S0VNRUdpLVFYQWRxTUVNSGlISVU4b2Rram5TNWZfREpMSnBMSWw3c3J4NzA5N0VqMjNqUXl4elE5VFNyRjctQldoNWo3YzBYclJJRlVnQ3QxQU5ibUgxeWZiUkJUMXZudFRWRUNpNHdCS004Q1E?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPSEUtV0RvUW9DTXZwOGtNbU9hT3o3bUY1R3J2U3ZwMXFFN29hUW50MHhtWUQyODRWdnNXM2lqLTNoeEROcndUaG8zODUwOGc5cjZsWkJYU2tORDNTNENQMFl4bzhqeG1XNUNRdy1tWFl5aU5fRlhZODBRRk1fTk15dTd2SnY2YUU4cE1wYm9zTzRLZmR2d041Y1l1RFlMS1lwd05nSUZ3aTdkQmJrTEZkQVpZX0hGMVVVM2hNQjQ1Z08yMm1iZGdQMzFvMG1wT1JLYURMX1pBU1NVcnk0UVl1RWln?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Shares Skyrocket, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPYUpmdElNRnJJSkVzOGptRzFobExlUGdodWk4eXRhXzBxaXpiQ1dTNzI3cEtwaTBlbzhLbm1NVzQ2cVBlRl9FcUg3YVUwcGVBMDdZMGlvMGZ2QTFUX2ViSnNsOU4tTXBwOWRnLURhQUpLLVdZdVRyeGtlTW11YzNaMG1qN1h5TzNGdzBDTkx4cXJ3QzFGNWY4NHM2VkZaaU1BTDM3WlVvTnlNYkRYekxxSGIwSUo?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen (RGEN) Starting To Look Attractive After Its Sharp Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQRlFrRzlnSmNELURHaFlhS0I0aDVWX3UzT042a3RuNmp5cHdKWk1nMlE2ZXBXaHhsT0U0RVU3ODZ4RXB2aHFpM0FyV0tJUTF5anlCRmhYSXh0UzZMbHB2eWtuVEdyVWRuTkdnanN0ekZQeTlnTFR6ckhGcEpvTXFYaHZFVlM0ckV1cm9lSmt1WFIwSVo3V21QQ3VIQ1VPR1hheU1Lb2FB?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Repligen (RGEN) Offering Value After A 28.5% Year To Date Share Price Decline", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNVXJkQUxyYW05UVNfejA3RU81SG50aGRBbTdsUWtIRUVWV2dPX1h4QVN5MEtsaDNXbmtUOG9fR3p0RnVqUE5XdUw3WllFRUpIY0otUkc3emM2TmNIVmFpQy1ORDdPdV9JNGhRVWZqQ0tvUUZLZ1kxUWJJVlowcGxqTkN4OTcwTDYzTFZheWcyTkZPMnliOEF1WG55ZERqYnNXdWRvaWRB?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Repligen (RGEN) Shares Are Plunging Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQSmVyeFFVaWw5WDlsd3RKSm5oZXhLRDRvd3Y3SFNmUE5UUmw3WnFBQkRXa2pZR2lKY2NwakJRQ0lCaXdELXhKNzduVWRGZ0pMZk1JOUJSMThoYWFBTC1tNU9xeWF1djJ2TXJVUzhTaFMtRnN5cVdfTUNHaHh2R0V0bTRCekhpb1NTR0JTT2hzSTBzZkR4anpiQWF2ME9xM1U?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen slides 8.3% as CEO share sale disclosure weighs on sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNTGpReHNueXBMRXVGbi1lM1Rma0RUb09tejR5LTVEZ2JPckFRd29HZlAybmVJZWF1OHkwX1BuWDBmMUtsdUZhcXFUdXljX3gtdUdFaXl4LUREZDRzX3c5Wk1rUy0tVlNHb29WdFVKUkJ1bnp1Y3dJMVBhSG92RkZ4ZHp4UEY5ODBiaE1yYktDMThmS3BsMnpXeTNsLUtkNTZKbTI5bzVfSQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen plans a May 5 premarket earnings release and 8 a.m. webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPendyekJ2LV93bzhxWGk5S0hfbVRsZ1FaWWxocFRyMHk3WXoybTRxazVpdzlyc3FvZjM2WWdfZHlfXzJiR0pnRHptWnhyaUxUZzJvQ0Y4Ylc3YXFlZlZtX2FFVk1rM0RGcWNTd2M3V1ZXOHRVYnhiN1ZkWktkTTUyalNxY0hPbk1IWHlObWF0Q0Y2ekJMbjIyamgxZFBoLS01aVJaYQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Valuation Check After Mixed Share Price Returns And High P/E Multiple", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQbHpKSjdFWjhDRFJnd0lzY001XzVUdS1hNEpmcW1hZzhFdV8ydE5BSU9NQ1pDU2ZrVDVEUG1CMEoxN3pWdk92eF9IZ3UtYmNaNkFoUmZNMDZ0cG5qVHpEM1pDVmc3MDBhY29uMlUtNnJRekVXX0xSQ2ZZcHhQMzJuS3BvN1hfYW5lZ2RTVTBucFVIcE4ycGNQc0lLOWtGQzNFUUE?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNb1BzWEZYRkhydkxxUEF2ZUJOQVIyLTU1VlFubFM0TkgzZFNPM2QwWmYzaWhsQnFnZU5qQS05S1ZDLThwT3JKTnlxTGhMblZQTlFBb1NGS0h6TlMwdTBXMzVoWHZMV1JDVGFLSTQ1UEg4MG5RclE5X3BNMVdQQ1JoZG5RbTFfQnVIalVWa2s4SHBFdw?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Repligen (NASDAQ: RGEN) Eddleman trusts report passive stake under 5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOTVFyUWpURGhRYWcwdHkyOVpTUDViTmlyR1otREdJUDN6Qk5kSEZMdGVNZGdxZDEzWTZQQUJTSEd5eVNmSzB2cnU0MTdlMzdIanA0a3Mzb0FMSl9wejJxejlrcXlhVFFiSHBJQ0NxOVlKNG5UMlRBd2RuS3Y5VWRWaDZXYWV3dkNUcm1WVl9wUTB4Q2FUbEFYMjZSZ3pVMTlzS2lOd1FSVHlkMU5UU19EaE1oMWhMX1o2QlZJU1pwX29hVHdEUzJR?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 53, "sentiment_summary": {"positive": 17, "negative": 4, "neutral": 32, "score": 55, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 14.85, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 144.24, "latest_week": "2026-07-10", "one_week_move": 1.3, "four_week_move": 10.5, "twelve_week_move": 9.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.885223, "market_dynamics_buy_signal": false, "relative_strength": -9.112587, "fair_value_gap": -2.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.0167, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.3% over one week, +10.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 11}, {"label": "Market source", "count": 10}, {"label": "Stock Titan", "count": 6}, {"label": "simplywall.st", "count": 4}, {"label": "GuruFocus", "count": 3}, {"label": "AD HOC NEWS", "count": 2}, {"label": "Moomoo", "count": 2}, {"label": "Quiver Quantitative", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 53}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 18}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "53", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.3% over one week, +10.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Repligen (RGEN) Stock May Trade At Fair Value But At A Sales Premium"}], "updated_at": "2026-07-16T04:34:29.459926+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}